Site networks can be a powerful engine for this kind of change. When built on collaboration, not control, and focused on capability over conformity, they allow more sites to engage in research, more ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

Details are as follows: Abstract Title: Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly ...

Kevin Hall, a former senior investigator at NIH, says MAHA children’s report fails to address ultra-processed food threat ...

Parexel, a leading global clinical research organization (CRO) providing insights-driven clinical and consulting solutions to ...

Quatech Research Center, backed by Gorgio Holding, prepares to launch innovative anti-cancer drugs and nutritional supplements with global implications ...

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia.

When Juli comes home after work, her husband doesn’t regale her with stories about his photography business the way he once ...

Its president Ezri Abdul Wahab says the police should provide neutral status updates so that a suspect's right to a fair ...

Breathwork micro-breaks—brief bouts of structured breathing slotted between emails and calls—switch off the body’s ‘alert’ ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...